Henan Taloph Pharmaceutical Stock Co.,Ltd
SHH: 600222.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jingliang Li
- Employees
- 2,214
- Headquarters
- Zhengzhou, China
- IPO year
- 1999
- Market cap
- CN¥4.1B
- Website
- https://www.taloph.com
Loading 600222…
Loading profile data…Frequently asked questions about 600222
What does Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) do?
Henan Taloph Pharmaceutical Stock Co., Ltd. researches, produces, and sells Chinese and western medicines in China. It primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and other forms. The company's principal products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, pazufloxacin mesylate...
Where does 600222.SS trade?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) trades on the Shanghai Stock Exchange.
What sector is 600222.SS in?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Henan Taloph Pharmaceutical Stock Co.,Ltd?
Jingliang Li is the chief executive officer of Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS).
Where is Henan Taloph Pharmaceutical Stock Co.,Ltd headquartered?
Henan Taloph Pharmaceutical Stock Co.,Ltd is headquartered in China.
Does 600222.SS pay a dividend?
Yes — Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) paid a trailing twelve-month dividend of CNY 0.01 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600222.SS go public?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) completed its initial public offering in 1999.